Author
Aldo Lourenço Abbade Dettino
Also Known As
A. A. Dettino, A. L. A. Dettino, A.L.A. Dettino, Aldo A. Dettino, Aldo Dettino, Aldo L A Dettino, Aldo L. A. Dettino, Aldo L.A. Dettino, Aldo Lourenco Abbade Dettino, Aldo Lourenço Abadde Dettino
43
Publications
928
Citations
11
H-Index
23
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 4 | 4 | 225 |
2 | Cell Biology | 2 | 2 | 111 |
3 | Nursing | 1 | 1 | 45 |
4 | Public Health | 1 | 1 | 45 |
5 | Family Medicine | 1 | 1 | 45 |
Aldo Lourenço Abbade Dettino
×
10
Publications
380
Citations
10
H-Index
| Year | Citations | |
|---|---|---|
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park, Metastatic Urothelial CancerUrologyGenitourinary CancerSelect Fgfr AlterationsMedicine | 2023 | 69 |
2016 | 57 | |
2015 | 54 | |
2013 | 48 | |
2015 | 45 | |
2016 | 39 | |
2017 | 28 | |
2021 | 17 | |
2009 | 13 | |
2010 | 10 |
Page 1
Page 1